November 22nd 2024
Pediatric melanoma, though rare, is the deadliest skin cancer in children, with 300-500 US cases annually.
Expert Illustrations & Commentaries™: A Deeper Look at the Pathogenesis of Hidradenitis Suppurativa (HS)
View More
Cancer Summaries and Commentaries™: Clinical Updates in Melanoma from Philadelphia
View More
Dermalorian™ Webinar Series on Moderate to Severe Atopic Dermatitis
November 21, 2024 - December 5, 2024
View More
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Expert Illustrations & Commentaries™: Picturing the Potential Role of OX40 and OX40L Inhibitors in Atopic Dermatitis
View More
Hidradenitis Suppurativa (HS): Deepening Foundations of Knowledge in Disease Pathogenesis, Disease Severity Assessment, and Treatment Decision-Making
View More
Clinical Consultations™: Optimizing Treatment Outcomes for Patients with Generalized Pustular Psoriasis
View More
Advances in™ Atopic Dermatitis: Addressing Unmet Needs in Patients With Skin of Color
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Patient, Provider & Caregiver Connection™: Understanding the Patient Journey to Provide Personalized Care for Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Practice Techniques to Optimize Diagnosis and Treatment Strategies in Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
Ceramide-dominant barrier repair moisturizer improves AD
September 1st 2001Washington - A ceramide-dominant barrier repair moisturizer (TriCeram) is a valuable adjuvant in the treatment of atopic dermatitis, according to the results of a study presented by University of California, San Francisco dermatology researchers at the annual meeting of the Society for Investigative Dermatology.
Topical growth factor rejuvenates photodamage
September 1st 2001Washington - A conditioned, growth factor-containing nutrient solution derived from the manufacture of bioengineered skin appears to be a unique, effective topical treatment for rejuvenation of cutaneous photodamage, according to studies presented at the annual meeting of the Society for Investigative Dermatology.